Atlas FDA

ADVIA Centaur HBsAgII (HBsII)

FDA premarket approval P110041/S014 · decided 2025-06-04

Approval details

PMA number
P110041
Supplement
S014
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
ADVIA Centaur HBsAgII (HBsII)
Generic name
Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
Applicant
Siemens Corp.
Date received
2024-08-13
Decision date
2025-06-04
Days to decision
295 days
Decision code
APPR
Product code
LOM
Advisory committee
Microbiology
Expedited review
No
Location
Tarrytown, NY
Statement
Approval for the biotin remediated ADVIA Centaur HBsAgII assay.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
DIMENSION VISTA DIGITOXIN CALIBRATOR - DGTX CAL (K103360)Siemens Corp.2010-12-17
KOORDINANT ANGIOGRAPHIC AND OPERATING ROOM MODEL X-RAY TABLE FAMILY (K993947)Siemens Corp.1999-12-21
AX WORKSTATION DR-VIEWER SOFTWARE OPTION (K992925)Siemens Corp.1999-11-23
HIGH ENDS GRADIENTS/MAGNETOM SYMPHONY SYSTEM (K991652)Siemens Corp.1999-08-03
SOMATOM PLUS 4 WITH SLIDING GANTRY OPTION (K991600)Siemens Corp.1999-06-09
FUNCTIONAL MRI PACKAGE FOR MAGETETOM VISION MR (K984221)Siemens Corp.1999-02-12
PERFUSION PACKAGE FOR MAGNETOM VISION AND SYMPHONY SYSTEMS (K984224)Siemens Corp.1999-02-02
PERFUSION CT (COMPUTED TOMOGRAPHY) SOFTWARE PACKAGE (K982536)Siemens Corp.1998-11-24